**Description:** The dataset includes scans of 46 Alzheimer’s sufferers and 23 healthy elderly people. Many scans were collected of each participant at intervals from 2 weeks to 2 years. The study was designed to investigate the feasibility of using MRI as an outcome measure for clinical trials of Alzheimer’s treatments. It includes a total of 708 scans and should be of particular interest for work on longitudinal biomarkers and image analysis.<br>
**Modality:** The dataset uses MRI (Magnetic Resonance Imaging) as its modality. It does not include other modalities like rs-fMRI, task-fMRI, T1, DTI, DWI, EEG, etc.<br>
**Data Availability:** The dataset is publicly available and can be found at the official MIRIAD website. The datasets and information available in MIRIAD are free for academic use
